Emerging challenges in pharmacotherapy research on attention-deficit hyperactivity disorder-outcome measures beyond symptom control and clinical trials

Wong, ICK; Banaschewski, T; Buitelaar, J; Cortese, S; Dopfner, M; Simonoff, E; Coghill, D; Asherson, P; Santosh, P; Smirnoff, E; Sonuga-Barke, EJ; Taylor, E; Daley, D; Hollis, C; Ferrin, M; Dittmann, RW; Holtmann, M; Rothenberger, A; Brandeis, D; Ste

Coghill, D (reprint author), Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia.

LANCET PSYCHIATRY, 2019; 6 (6): 528

Abstract

Although pharmacological therapies are recommended as a key component in the treatment of attention-deficit hyperactivity disorder, their use continue......

Full Text Link